Benacillin Long Acting Penicillin Injection

Hazard statements

This product is classified as: Not classified as hazardous according to the criteria of SWA Australia. Not a Dangerous Good according to Australian Dangerous Goods (ADG) Code, IATA and IMDG/IMSBC criteria. Not Hazardous - No criteria found

Precautionary statements

Not Hazardous - No criteria found

SUSMP Classification

S4

ADG classification

None allocated. Not a Dangerous Good under the ADG Code

UN Number

None allocated

Signal word

NONE. Not hazardous

Prevention

P102: Keep out of reach of children. P262: Do not get in eyes, on skin, or on clothing. P281: Use personal protective equipment as required.

Response

P337 If eye irritation persists seek medical attention P352: Wash with plenty of soap and water. P301+P330+P331 IF SWALLOWED Rinse mouth. Do NOT induce vomiting P370+P378: Not combustible. Use extinguishing media suited to burning materials.

Storage

P403+P235: Store in a well-ventilated place. Keep cool.

Disposal

P501: Dispose of contents and containers as specified on the registered label. Emergency Overview Physical Description & Colour: White micronised suspension which settles on standing, but disperses on shaking. Odour: Characteristic antibiotic odour.

Health hazards

no significant risk factors have been found for this product. However, significant ingredients are antibiotics. Any person with a history of allergies to this class of substances should avoid all contact with this product as it may cause sensitisation.

Potential health effects

This is a pharmacologically active preparation, and contact should be avoided except for its intended veterinary use. If you have come into contact with this product, and you experience any unusual symptoms, seek medical attention. As for benzyl penicillin sodium, severe, usually transient reactions with symptoms of severe anxiety and agitation, psychotic reactions, including visual and auditory disturbances, seizures, tachycardia and hypertension, cyanosis, and a sensation of impending death have occasionally been reported with procaine penicillin and may be due to accidental intravascular injection. Procaine has been implicated as a cause of these reactions, especially after injection of high doses. This reaction has been termed non-allergic, pseudoallergic, pseudoanaphylactic, or Hoigne’s syndrome. Procaine penicillin should not be injected intravascularly since ischaemic reactions may occur. Inhalation Short Term Exposure: Significant inhalation exposure is considered to be unlikely. Available data indicates that this product is not harmful. In addition product is unlikely to cause any discomfort or irritation. Long Term Exposure: No data for health effects associated with long term inhalation. Skin Contact: Short Term Exposure: Available data indicates that this product is not harmful. It should present no hazards in normal use. However product may be irritating, but is unlikely to cause anything more than mild transient discomfort. Long Term Exposure: No data for health effects associated with long term skin exposure. Eye Contact: Short Term Exposure: Exposure via eyes is considered to be unlikely. This product may be mildly irritating to eyes, but is unlikely to cause anything more than mild discomfort which should disappear once product is removed. Long Term Exposure: No data for health effects associated with long term eye exposure. Ingestion: Short Term Exposure: Significant oral exposure is considered to be unlikely. However, this product may be irritating to mucous membranes but is unlikely to cause anything more than transient discomfort. Long Term Exposure: No data for health effects associated with long term ingestion. Carcinogen Status: SWA: No significant ingredient is classified as carcinogenic by SWA. NTP: No significant ingredient is classified as carcinogenic by NTP. IARC: No significant ingredient is classified as carcinogenic by IARC.